Coronavirus Update: Big Trials, New Vaccine Platforms, And Fake Chloroquine In Africa

In addition to our daily in-depth coverage of key events relating to the coronavirus, we’re bringing you a periodic round-up of other pandemic developments. This edition covers events at the national and EU level. 

Covid19_Map_Africa
Africa is a region of growing concern amid the coronavirus pandemic • Source: Shutterstock

This latest Pink Sheet coronavirus update looks at new vaccine platforms being developed by companies and researchers in the US and Germany, the need to ensure equitable access to any new therapeutics or vaccines, and threats to patients in Africa, including the discovery of fake chloroquine tablets in Cameroon and DRC.

International drug regulators have again stressed that large, multi-center, multi-arm clinical trials of potential COVID-19 treatments and vaccines are needed...

Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

More from Europe

  • EU Biosimilar Filings, Opinions And Approvals

     
    • By 

    <p>Executive Summary</p> <p>A list of EU biosimilar filings, CHMP opinions and EU marketing authorizations, including details of the biosimilar company, the brand name/INN, indication(s), the reference product/company, and the date and type of event.</p>

  • EU Pharma Reform: What You Need to Know Now

     

    As the reform of the EU pharmaceutical legislation progresses through the legislative process, the Pinks Sheet offers an infographic highlighting some of the key changes being proposed that will reshape the way drug companies run their business.

  • New EU Approvals

    <p>Executive Summary<p> <p>The Pink Sheet's list of EU centralized approvals of new active substances has been updated to add six new products, incl/ding Ixchiq, Valneva's chikungunya virus vaccine</p>

More from Geography